The global hematology analyzer market value was more than $1,762 million in 2020. The global hematology analyzer market is forecast to grow at a compound annual growth rate (CAGR) of more than 6.1% during the forecast period from 2021-2027.
A hematocrit analyzer is a highly specialized machine that counts the types of red, white, and platelets found in a blood sample. It also measures hemoglobin levels and hematocrit. Automated alarms are programmable to notify users when results are outside the reference range. It is used for detecting, monitoring, diagnosing, and subsequently screening diseases, especially hemophilia, blood cancer, and blood clots. Hematology diagnoses diseases such as leukemia, anemia, blood transfusions, malignant lymphomas, and others.
Factors Affecting the Market
• Among the factors driving the growth of this market is the rise in the prevalence of diseases such as anemia, cancers, hemorrhagic conditions, and infections in the blood.
• Factors fueling the growth of the hematology analyzer market include the development of technologically advanced analyzers and the growth in demand for automated analyzers and a trend toward high sensitivity analyzers.
• Due to their advanced features and automation, hematology analyzers are very expensive. It could inhibit the growth of the market. In addition, stringent regulations for hematology analyzers may also limit the market growth.
• Hematology analyzer manufacturers can take advantage of growth opportunities in emerging economies.
Covid-19 Impact
Throughout the world, the spread of COVID-19 has disrupted healthcare workflows. Multiple industries, including several sub-disciplines of health care, have temporarily shut their doors due to the disease. Globally, the growing use of hematology parameters for COVID-19 will drive the hematology analyzer market. Research institutions are conducting several studies, and many hospitals utilize hematology analyzers to monitor and test COVID-19 patients without spreading the virus. Chinese research studies recommended including white blood cells (WBC) and C-reactive protein (CRP) in laboratory tests for early monitoring of COVID-19 infection for practical and efficient screening.
An overview of the Asia-Pacific Market
Hematology analyzer market players in Asia-Pacific will register the fastest growth rate over the forecast period. Due to the region's aging population, growing healthcare infrastructure, increasing prevalence of blood diseases, rising disposable incomes, and well-established domestic companies. Factors such as the increasing population and the economic growth of developing countries like India and China have also contributed to the rise of hematology analyzers in Asia. In addition to technological advancements, government investments and funds, especially in developing countries like India and China, are also expected to contribute to market growth.
Key Players in the Market
The leading prominent companies in the global hematology analyzer market are:
Aim of the Report
The global hematology analyzer market segmentation focuses on End User, Product & Service, Type, and Region.
Segmentation based on End-User
Segmentation based on Type
Segmentation based on Product & Service
Segmentation based on Region
